|
Dr. Carbone is Director of the Thoracic Oncology Program at Loyola University in Chicago, where he is also a tenured Professor at the Cancer Center, Department of Pathology. Previously, Dr. Carbone held scientific and academic positions at the National Institutes of Health (NIH), and at the University of Chicago. He is a board certified pathologist, and a past recipient of the NIH's prestigious Fogarty Fellowship. During his fellowship at the NIH, Dr. Carbone obtained his Ph.D. in Human Pathology through a combined research program between the University of Roma and the NIH. He is well-known for his groundbreaking research that identified the SV40 virus -- previously characterized only as a polio vaccine contaminant -- as a human carcinogen in mesothelioma, and for discovering that genetic predisposition to mineral fiber carcinogenesis is the cause of a mesothelioma epidemic in Turkey. More recently, Dr. Carbone's work has identified the mechanisms of asbestos carcinogenesis and co-carcinogenesis with SV40. Dr. Carbone's work in mesothelioma has been acknowledged by the National Cancer Institute (NCI), the American Cancer Society, and other leading research institutions, which have awarded him numerous grants in recent years -- including a $9.5M PO-1 in 2006 from the NCI to study the pathogenesis of mesothelioma. Dr. Carbone has authored nearly 200 publications, including original research articles, books, and book chapters. He is a graduate of the Medical School of Rome, and obtained board certification in Anatomic Pathology from both the University of Roma and the University of Chicago. | 